These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 31591677)

  • 1. Osteoclastic microRNAs and their translational potential in skeletal diseases.
    Inoue K; Nakano S; Zhao B
    Semin Immunopathol; 2019 Sep; 41(5):573-582. PubMed ID: 31591677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Emerging Role of MicroRNAs in Bone Diseases and Their Therapeutic Potential.
    Bravo Vázquez LA; Moreno Becerril MY; Mora Hernández EO; León Carmona GG; Aguirre Padilla ME; Chakraborty S; Bandyopadhyay A; Paul S
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as Potential Targets for Treatment of Osteoclast-Related Diseases.
    Li H; Zhai Z; Qu X; Xu J; Qin A; Dai K
    Curr Drug Targets; 2018; 19(5):422-431. PubMed ID: 27138766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in Osteoclastogenesis and Function: Potential Therapeutic Targets for Osteoporosis.
    Ji X; Chen X; Yu X
    Int J Mol Sci; 2016 Mar; 17(3):349. PubMed ID: 27005616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in bone diseases.
    Gennari L; Bianciardi S; Merlotti D
    Osteoporos Int; 2017 Apr; 28(4):1191-1213. PubMed ID: 27904930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk of MicroRNA and hydrogen sulfide: A novel therapeutic approach for bone diseases.
    Zhai Y; Tyagi SC; Tyagi N
    Biomed Pharmacother; 2017 Aug; 92():1073-1084. PubMed ID: 28618652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Osteoclastogenesis and Bone Resorption by miRNAs.
    Inoue K; Ng C; Xia Y; Zhao B
    Front Cell Dev Biol; 2021; 9():651161. PubMed ID: 34222229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of microRNAs in osteoclasts and osteoporosis.
    Tang P; Xiong Q; Ge W; Zhang L
    RNA Biol; 2014; 11(11):1355-63. PubMed ID: 25692234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RBP-J-Regulated miR-182 Promotes TNF-α-Induced Osteoclastogenesis.
    Miller CH; Smith SM; Elguindy M; Zhang T; Xiang JZ; Hu X; Ivashkiv LB; Zhao B
    J Immunol; 2016 Jun; 196(12):4977-86. PubMed ID: 27183593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of downregulated microRNAs during osteoclast formation and osteoporosis progression.
    Ma Y; Shan Z; Ma J; Wang Q; Chu J; Xu P; Qin A; Fan S
    Mol Med Rep; 2016 Mar; 13(3):2273-80. PubMed ID: 26783047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA functions in osteogenesis and dysfunctions in osteoporosis.
    van Wijnen AJ; van de Peppel J; van Leeuwen JP; Lian JB; Stein GS; Westendorf JJ; Oursler MJ; Im HJ; Taipaleenmäki H; Hesse E; Riester S; Kakar S
    Curr Osteoporos Rep; 2013 Jun; 11(2):72-82. PubMed ID: 23605904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption.
    Mizoguchi F; Izu Y; Hayata T; Hemmi H; Nakashima K; Nakamura T; Kato S; Miyasaka N; Ezura Y; Noda M
    J Cell Biochem; 2010 Apr; 109(5):866-75. PubMed ID: 20039311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Bone Metabolism by microRNAs.
    Taipaleenmäki H
    Curr Osteoporos Rep; 2018 Feb; 16(1):1-12. PubMed ID: 29335833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DDR2 (discoidin domain receptor 2) suppresses osteoclastogenesis and is a potential therapeutic target in osteoporosis.
    Zhang Y; Su J; Wu S; Teng Y; Yin Z; Guo Y; Li J; Li K; Yao L; Li X
    Sci Signal; 2015 Mar; 8(369):ra31. PubMed ID: 25805889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiRNAs in bone diseases.
    Moore BT; Xiao P
    Microrna; 2013; 2(1):20-31. PubMed ID: 25070712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in bone development and their diagnostic and therapeutic potentials in osteoporosis.
    Suttamanatwong S
    Connect Tissue Res; 2017 Jan; 58(1):90-102. PubMed ID: 26963177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs involved in bone formation.
    Papaioannou G; Mirzamohammadi F; Kobayashi T
    Cell Mol Life Sci; 2014 Dec; 71(24):4747-61. PubMed ID: 25108446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein phosphatase 2A as a new target for downregulating osteoclastogenesis and alleviating titanium particle-induced bone resorption.
    Wang L; Guo X; Zhou W; Ding Y; Shi J; Wu X; Liu Y; Xu Y; Yang H; Geng D
    Acta Biomater; 2018 Jun; 73():488-499. PubMed ID: 29656074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of microRNAs in bone remodeling and its therapeutic implications for osteoporosis.
    Feng Q; Zheng S; Zheng J
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29848766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of microRNAs in progenitor cell commitment and osteogenic differentiation in health and disease (Review).
    Valenti MT; Dalle Carbonare L; Mottes M
    Int J Mol Med; 2018 May; 41(5):2441-2449. PubMed ID: 29393379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.